InvestmentApr 28, 2026, 07:02 AM
CLYM Raises $110M in Private Placement of Stock & Warrants
AI Summary
Climb Bio, Inc. (CLYM) announced a private placement to raise approximately $110.0 million in gross proceeds. The company is selling 9,481,000 shares of common stock at $9.50 per share and 2,106,000 pre-funded warrants at $9.4999 per warrant. The placement, expected to close around April 29, 2026, saw participation from new and existing institutional investors including Adage Capital Partners, RA Capital Management, and Redmile.
Key Highlights
- Raised approximately $110.0 million in gross proceeds from private placement.
- Sold 9,481,000 shares of common stock at $9.50 per share.
- Sold 2,106,000 pre-funded warrants at $9.4999 per warrant.
- Pre-funded warrants have an exercise price of $0.0001 per share.
- Private placement expected to close on or about April 29, 2026.
- Key investors include Adage Capital Partners, RA Capital Management, and Redmile.
- Leerink Partners and Piper Sandler acted as lead placement agents.